Exhaled volatile organic compounds analyzed via GC-IMS as non-invasive biomarkers for severity stratification and prognosis prediction in critical illness.
While single-modal VOC profiling has limited prognostic performance due to the heterogeneity of critical illness outcomes, the distinct differential signatures identified here provide a solid foundation for future research.